Document is current

Any future updates will be listed below

Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

Crossref DOI link: https://doi.org/10.1186/s13046-025-03311-z

Published Online: 2025-02-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark